University of California San Francisco
Give to UCSFIn the third installment of UCSF’s three-part series, “COVID-19: The Path Forward,” a panel of health and policy experts met March 23 to examine COVID-19's impact on our society and look ahead to how we rebuild and prepare for future pandemics.
A survey of medical workers and community residents in six Bay Area Counties in the early weeks of vaccine rollout found that Black, Latinx and Asian individuals were more likely than white individuals to report concern that the government had rushed the approval process, and they were less likely to trust the companies making the vaccines.
For some people a sales ban that takes the temptation out of the workplace may not be enough.
A panel of health experts and government officials addressed the myriad issues related to COVID-19, including health disparities before and during the pandemic, public partnerships, and how communities can better address inequities to prevent the next crisis.
Almost 90 percent of infectious travelers could be detected with rapid SARS-CoV-2 tests at the airport, and most imported infections could be prevented with a combination of pre-travel testing and a five-day post-travel quarantine that would only lift with a negative test result, according to a computer simulation by UCSF researchers.
In the week after former President Donald J. Trump tweeted about “the Chinese virus,” the number of coronavirus-related tweets with anti-Asian hashtags rose precipitously, a new study from UCSF has found.
We asked UCSF infectious disease expert Monica Gandhi, MD, MPH, to unpack some of the big questions around vaccine science, such as how the Johnson & Johnson vaccine differs, how well it works against the new variants, and whether you should be worried about transmitting the virus after vaccination.
There is a big, global problem: viruses such as HIV and COVID-19 mutate, but treatments for them don’t.
UCSF gathered leading Bay Area scientists and clinicians to reflect on the scientific challenges and breakthroughs of the past year since COVID-19 was declared a pandemic.
This will be one of the first and largest studies to examine the impact of factors like age and stress on vaccination effectiveness.
Further studies may reveal different patterns, including the possibility that evidence of abuse may not be apparent for months to follow, or failure by clinicians to identify abuse.
New results from an ongoing collaborative effort to slow the spread of COVID-19 shows that the prevalence of a coronavirus lineage, characterized by the L452R substitution and two other mutations in the virus’s spike protein, has significantly increased in recent months.
UCSF scientists have formed a research alliance with pharmaceutical firm Eli Lilly and Company aimed at better understanding autoimmune diseases and fostering the development of new therapies
Millie Hughes-Fulford, a UCSF scientist who flew in June 1991 aboard the first space shuttle mission dedicated to biomedical studies, died on Feb. 2 at the age of 75. S
Susan Acton discovered ACE2 while searching for new cardiovascular drugs. Decades later, she was surprised to see it popping up in the news once COVID took hold.
A new study finds that inherited genetic variation plays a role in who is likely to benefit from checkpoint inhibitors, which release the immune system’s brakes so it can attack cancer.
The new center will provide an integrated platform for basic and clinical research, bringing together vascular biology, immunology, and neuroscience.